Save time and get answers to complex questions with AI chat
Campath litigation germany?Alogliptin benz cost?Abbvie humira patent cliff navigation success?When will tenofovir alafenide come off patent in canada?When is the expected fda decision date for apotex's ruxolitinib resubmission?
See the DrugPatentWatch profile for Finerenone
There isn’t a single “finerenone EU patent expiration date.” There are multiple patent families around finerenone (the compound itself, formulations, uses, methods of manufacture, etc.), and each can have its own expiry. In Europe, the key question usually is the term for the core “compound” (BAY-94-8862) patent plus any European SPC (supplementary protection certificate) tied to a marketing authorization. What you should know - The European term for a compound patent is typically 20 years from the earliest filing date, plus any SPC that may extend protection for a medicinal product. - In addition to patents, European data and market exclusivity protect new active substances and indications (the standard EU regime is often summarized as 8+2+1 years for data/market protection, though exact terms can vary by substance and indication). This can delay generic entry even after a patent expires. - Finerenone has multiple patent families (compound, salts, formulations, methods, etc.), so there may be several expiration dates depending on the specific claim set and jurisdiction within the EU. How to obtain the exact EU expiration dates - Check the European Patent Register (epo.org) or Espacenet: - Search for finerenone or BAY-94-8862. - Identify the core “claim” patent family for the compound and note the earliest priority date and grant date. - Look for any linked SPCs: identify the marketing authorization (MA) for finerenone in EU member states and see the SPC term. - For regulatory exclusivity: - Review EU data/market protection status for finerenone (new active substance, indications). This is separate from patent term and can extend protection beyond patent expiry. - Expect multiple expiry dates if there are several patent families; the earliest enforceable expiry among active families is what blocks generic entry, subject to SPCs and regulatory exclusivity. If you’d like, I can guide you step-by-step through a search plan or help interpret results from Espacenet and the EU Patent Register. I can also summarize the current status if you can share any specific patent family numbers or if you want me to outline exactly which families to look for (compound vs. salts vs. formulations vs. methods). Note that I can’t fetch live data in this chat, but I can tell you exactly what to look for and how to compute the expiry once you have the patent family details.
Other Questions About Finerenone :